In addition, the immune cell scores in Supplemental Fig. S5 demonstrate that the mice treated with combinations of XRT, MerTK ASO, αPD1, and αCTLA4 had a seemingly higher abundance of neutrophils, CD8+ T cells, dendritic cells (DCs), macrophages, and CD45+ cells in the primary tumor. This evidence concerns the gene MERTK and neoplasm.